SUN-LB22 PLK1 as a New Treatment Target for Adrenocortical Carcinoma

Background: Adrenocortical carcinoma (ACC) is an aggressive malignancy with limited medical treatment options. We previously identified polo-like kinase 1 (PLK1) as one of most overexpressed genes in ACC; thus PLK1 represents a potential treatment target for this cancer type. Some PLK1 inhibitors ar...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Endocr Soc
Main Authors: Smith, Gabrielle, Liang, Raimunde, Chortis, Vasileios, Khan, Sana, Lippert, Juliane, Hantel, Constanze, Altieri, Barbara, Fassnacht, Martin, Foster, Paul Alexander, Ronchi, Cristina Lucia
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2020
Assuntos:
Tumor Biology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208647/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.2164
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares